Literature DB >> 26593776

A new era in psoriasis and psoriatic arthritis therapy: new mechanisms of action and the introduction of biogeneric drugs.

Morton Scheinberg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26593776     DOI： 10.1016/j.rbr.2015.09.001

Source DB:  PubMed          Journal:  Rev Bras Reumatol        ISSN： 0482-5004


× No keyword cloud information.
  1 in total

1.  Secukinumab - First in Class Interleukin-17A Inhibitor for the Treatment of Psoriasis.

Authors:  Kiran Godse
Journal:  Indian J Dermatol       Date:  2017 Mar-Apr       Impact factor: 1.494
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.